Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.14 USD | +0.96% | +24.11% | +77.40% |
May. 14 | Taysha Gene Therapies Q1 Net Loss Narrows, Revenue Declines -- Shares Down After Hours | MT |
May. 14 | Transcript : Taysha Gene Therapies, Inc., Q1 2024 Earnings Call, May 14, 2024 |
Financials (USD)
Sales 2024 * | 11.7M | Sales 2025 * | 4.91M | Capitalization | 587M |
---|---|---|---|---|---|
Net income 2024 * | -90M | Net income 2025 * | -102M | EV / Sales 2024 * | 44.8 x |
Net cash position 2024 * | 62.72M | Net cash position 2025 * | 147M | EV / Sales 2025 * | 89.7 x |
P/E ratio 2024 * |
-7.46
x | P/E ratio 2025 * |
-6.31
x | Employees | 52 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.55% |
Latest transcript on Taysha Gene Therapies, Inc.
1 day | +0.96% | ||
1 week | +24.11% | ||
Current month | +29.22% | ||
1 month | +21.94% | ||
3 months | +64.40% | ||
6 months | +100.00% | ||
Current year | +77.40% |
Managers | Title | Age | Since |
---|---|---|---|
Sean Nolan
CEO | Chief Executive Officer | 56 | 20-02-29 |
Kamran Alam
DFI | Director of Finance/CFO | 46 | 20-07-31 |
President | 58 | 20-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Philip Donenberg
BRD | Director/Board Member | 63 | 20-08-30 |
Sean Nolan
CEO | Chief Executive Officer | 56 | 20-02-29 |
Sean Stalfort
BRD | Director/Board Member | 53 | 23-06-20 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 3.14 | +0.96% | 1,400,338 |
24-05-15 | 3.11 | +21.01% | 4,689,493 |
24-05-14 | 2.57 | +7.08% | 2,706,539 |
24-05-13 | 2.4 | +2.56% | 923,238 |
24-05-10 | 2.34 | -7.51% | 1,407,720 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+77.40% | 582M | |
+33.37% | 49.46B | |
+1.55% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.57% | 26.61B | |
-21.00% | 18.64B | |
+7.36% | 13.16B | |
+28.30% | 12.55B | |
+23.80% | 12.1B |
- Stock Market
- Equities
- TSHA Stock